Share of the pharma major fell about 4 per cent in the first one hour of the trade on Friday. Experts see concerns over the US business, as well as, pressure on operating performance as key drags. Despite near-term headwinds, most brokerage firms maintained their rating and target prices but slashed earnings per share (EPS) estimates for FY23-24.
Top 10 PSU performers in CY24. Here’s how much they have returned
As we are at the fag end of 2024, a look back at the performance of PSU stocks shows BSE PSU index delivering nearly 29%
December 21, 2024